NanoSort, Inc. Awarded NIH “Lab to Marketplace” SBIR Grant to Develop Next-Generation Flow Cytometer and Cell Sorter
San Diego, CA, July 14, 2011 --(PR.com)-- The National Institutes of Health awarded technology start-up NanoSort, Inc. a 2 year, $698,000 small business innovation research (SBIR) grant. Granted by NIH’s National Center for Research Resources (NCRR), this SBIR will enable NanoSort to advance their development of next-generation personal flow cytometers. NanoSort employs lab-on-a-chip technology to drastically reduce the size and cost of flow cytometers while maintaining high performance.
“We have developed unique technologies that allow us to provide a much needed and affordable fluorescent-activated cell sorter with a drastically smaller footprint and cost and equal or improved capabilities relative to current market leaders,” said Dr. Jose Morachis, CEO of NanoSort. “Our goal,” continued Dr. Morachis, “is to democratize flow cytometry.”
Flow cytometry is a widely used biomedical technique that can enumerate, analyze, and sort cells and particles. NanoSort’s R&D will translate technologies developed at UC San Diego by Professor Yuhwa Lo into products that meet market needs in advanced biomedical research and point-of-care clinics. According to Dr. Morachis, NanoSort aims to substantially extend the original technology with the invention of the COlor-Space-Time (COST) coding technique, enabling multi-parameter detection using a single photomultiplier tube (PMT) detector.
Nanosort, Inc. is a development-stage biomedical device company focused on building innovative flow cytometry technologies for the research, drug discovery, and diagnostic markets.
###
For additional information visit http://www.nanosort.net
Contact: email info@nanosort.net
“We have developed unique technologies that allow us to provide a much needed and affordable fluorescent-activated cell sorter with a drastically smaller footprint and cost and equal or improved capabilities relative to current market leaders,” said Dr. Jose Morachis, CEO of NanoSort. “Our goal,” continued Dr. Morachis, “is to democratize flow cytometry.”
Flow cytometry is a widely used biomedical technique that can enumerate, analyze, and sort cells and particles. NanoSort’s R&D will translate technologies developed at UC San Diego by Professor Yuhwa Lo into products that meet market needs in advanced biomedical research and point-of-care clinics. According to Dr. Morachis, NanoSort aims to substantially extend the original technology with the invention of the COlor-Space-Time (COST) coding technique, enabling multi-parameter detection using a single photomultiplier tube (PMT) detector.
Nanosort, Inc. is a development-stage biomedical device company focused on building innovative flow cytometry technologies for the research, drug discovery, and diagnostic markets.
###
For additional information visit http://www.nanosort.net
Contact: email info@nanosort.net
Contact
NanoSort
Jose Morachis
(951) 966-4963
nanosort.net
Contact
Jose Morachis
(951) 966-4963
nanosort.net
Categories